AR008304A1 - Procedimiento para la obtención de formulaciones aplicables de manera oral de ácidos quinolon-o naftiridoncarboxílicos y granulado preparado por mezclado. - Google Patents
Procedimiento para la obtención de formulaciones aplicables de manera oral de ácidos quinolon-o naftiridoncarboxílicos y granulado preparado por mezclado.Info
- Publication number
- AR008304A1 AR008304A1 ARP970103769A ARP970103769A AR008304A1 AR 008304 A1 AR008304 A1 AR 008304A1 AR P970103769 A ARP970103769 A AR P970103769A AR P970103769 A ARP970103769 A AR P970103769A AR 008304 A1 AR008304 A1 AR 008304A1
- Authority
- AR
- Argentina
- Prior art keywords
- water
- acids
- mixture
- naftiridoncarboxylic
- quinolon
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 239000002253 acid Substances 0.000 title abstract 3
- 150000007513 acids Chemical class 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 238000005469 granulation Methods 0.000 title 1
- 230000003179 granulation Effects 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- SPFYMRJSYKOXGV-UHFFFAOYSA-N Baytril Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 SPFYMRJSYKOXGV-UHFFFAOYSA-N 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 229960000740 enrofloxacin Drugs 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Un procedimiento para la obtención de formulaciones aplicables de forma oral de los ácidos quinolon- o naftiridoncarboxílicos, por mezclado de losácidos quinolon- o naftiridoncarboxílicos como tales o en forma de sus sales o derivados solublese n agua, preferentemente en forma de sus soluciones acuosassalinas, con el ácido embónico como tal o en forma de sus sales o derivados solubles en agua, preferentemente en forma de su solución acuosa salina, enpresencia de un excipiente, encaso d ado en presencia de productos auxiliares, en el caso de mezclas secas en presencia de agua, y la mezclaobtenida se transforma, en caso dado, en otras formas listas para su aplicación. En particular se obtiene unacomposición e n la cual el productoactivo empleado es una sal soluble en agua de enrofloxacin. El procedimiento permite obtener granulados preparados por mezclado.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19633480A DE19633480A1 (de) | 1996-08-20 | 1996-08-20 | Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR008304A1 true AR008304A1 (es) | 1999-12-29 |
Family
ID=7803084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970103769A AR008304A1 (es) | 1996-08-20 | 1997-08-19 | Procedimiento para la obtención de formulaciones aplicables de manera oral de ácidos quinolon-o naftiridoncarboxílicos y granulado preparado por mezclado. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5808076A (es) |
| EP (1) | EP0920317B1 (es) |
| JP (1) | JP4338222B2 (es) |
| KR (1) | KR100493577B1 (es) |
| CN (1) | CN1113651C (es) |
| AR (1) | AR008304A1 (es) |
| AT (1) | ATE260657T1 (es) |
| AU (1) | AU3942797A (es) |
| BR (1) | BR9711338B1 (es) |
| CA (1) | CA2263584C (es) |
| DE (2) | DE19633480A1 (es) |
| DK (1) | DK0920317T3 (es) |
| ES (1) | ES2213829T3 (es) |
| HK (1) | HK1022435A1 (es) |
| MY (1) | MY117606A (es) |
| TW (1) | TW518226B (es) |
| WO (1) | WO1998007428A1 (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100365679B1 (ko) * | 2000-04-03 | 2002-12-26 | 주식회사 엘지생명과학 | 기호성이 우수한 엔로프록사신 프리믹스 조성물 및 그제조방법 |
| US6518252B2 (en) * | 2000-09-20 | 2003-02-11 | University Of Georgia Research Foundation, Inc. | Method of treating aquatic animals with an antimicrobial agent and chelating agent |
| US20020122824A1 (en) * | 2001-01-24 | 2002-09-05 | Francisco Cabrera | Solid phase dispersion of quinolone-or naphthyridonecarboxylic acids |
| US6589955B2 (en) | 2001-06-20 | 2003-07-08 | Bristol-Myers Squibb Company | Pediatric formulation of gatifloxacin |
| WO2003031443A1 (en) * | 2001-10-04 | 2003-04-17 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety |
| PT1594500E (pt) * | 2003-02-10 | 2010-12-17 | Bayer Schering Pharma Ag | Tratamento para doenças bacterianas dos órgãos respiratórios por aplicação local de fluoroquinolonas |
| ES2308171T3 (es) * | 2003-04-30 | 2008-12-01 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones. |
| DE10328666A1 (de) * | 2003-06-26 | 2005-01-13 | Bayer Healthcare Ag | Tabletten enthaltend Geschmacks-und/oder Aromastoffe |
| DE10337191A1 (de) * | 2003-08-13 | 2005-03-17 | Bayer Healthcare Ag | Neue Verwendung von Chinolon-Antibiotika |
| DE10340485B4 (de) * | 2003-09-03 | 2015-05-13 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden |
| DE10351448A1 (de) * | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften |
| PL1709044T5 (pl) | 2003-12-18 | 2014-03-31 | Morphochem Aktiengesellschaft Fuer Komb Chemie | Antybiotyki hybrydowe oksazolidynon-chinolon |
| US8158797B2 (en) * | 2003-12-18 | 2012-04-17 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Oxazolidinone-quinolone hybrid antibiotics |
| FR2896416B1 (fr) | 2006-01-24 | 2010-08-13 | Vetoquinol | Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine |
| CN100360131C (zh) * | 2006-01-24 | 2008-01-09 | 新昌国邦化学工业有限公司 | 一种掩味恩诺沙星的生产方法 |
| KR101148501B1 (ko) * | 2007-06-08 | 2012-05-25 | 광동 하이나팜 파마슈티칼 씨오., 엘티디. | 엔로플록사신 미세캡슐 제형 및 그 제조 방법 |
| EP2343089A4 (en) | 2008-09-23 | 2013-05-01 | Jaer S A Lab | USE OF XYLITOL OR DERIVATIVES THEREOF FOR MASKING THE TASTE OF CHEMOTHERAPEUTIC MEDICAMENTS OF THE CHINOLO-N-NAPHTHYRIDONE-CARBOXYLIC ACID GROUP FOR PIG DICULTINATION |
| US20160068527A1 (en) * | 2013-04-09 | 2016-03-10 | Cresset Biomolecular Discovery Ltd. | The Treatment of Inflammatory Disorders |
| CN103251552B (zh) * | 2013-05-30 | 2014-12-31 | 成都乾坤动物药业有限公司 | 一种恩诺沙星糊剂及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL266216A (es) * | 1960-07-12 | |||
| GB1174221A (en) * | 1968-01-08 | 1969-12-17 | Ici Ltd | Acid-addition Salts of Tetramisole |
| CH524372A (de) * | 1969-01-29 | 1972-06-30 | Ciba Geigy Ag | Verfahren zur Herstellung von stabilen Elixieren, welche therapeutisch verwendbare tricyclische basische Wirkstoffe in Form ihrer Mononatriumpamoate enthalten |
| DE3525335A1 (de) * | 1985-07-16 | 1987-01-22 | Bayer Ag | Embonate von chinoloncarbonsaeuren und ihren derivaten |
| US5281596A (en) * | 1986-02-19 | 1994-01-25 | Bayer Aktiengesellschaft | Antibacterial drugs for fish |
| JPS62192321A (ja) * | 1986-02-19 | 1987-08-22 | Bayer Japan Kk | 魚類用抗菌剤 |
| DE3719764A1 (de) * | 1987-06-13 | 1988-12-22 | Bayer Ag | Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung |
| US5232919A (en) * | 1987-11-13 | 1993-08-03 | Asta Pharma Aktiengesellschaft | Azelastine embonate and compositions which contain it |
| DE4032560A1 (de) * | 1990-10-13 | 1992-04-16 | Bayer Ag | 7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate |
-
1996
- 1996-08-20 DE DE19633480A patent/DE19633480A1/de not_active Withdrawn
- 1996-12-06 US US08/761,687 patent/US5808076A/en not_active Expired - Lifetime
-
1997
- 1997-08-07 ES ES97936690T patent/ES2213829T3/es not_active Expired - Lifetime
- 1997-08-07 EP EP97936690A patent/EP0920317B1/de not_active Expired - Lifetime
- 1997-08-07 WO PCT/EP1997/004302 patent/WO1998007428A1/de active IP Right Grant
- 1997-08-07 CN CN97197362A patent/CN1113651C/zh not_active Expired - Fee Related
- 1997-08-07 CA CA002263584A patent/CA2263584C/en not_active Expired - Fee Related
- 1997-08-07 JP JP51033898A patent/JP4338222B2/ja not_active Expired - Fee Related
- 1997-08-07 BR BRPI9711338-7A patent/BR9711338B1/pt not_active IP Right Cessation
- 1997-08-07 AT AT97936690T patent/ATE260657T1/de not_active IP Right Cessation
- 1997-08-07 DK DK97936690T patent/DK0920317T3/da active
- 1997-08-07 KR KR10-1999-7000990A patent/KR100493577B1/ko not_active IP Right Cessation
- 1997-08-07 AU AU39427/97A patent/AU3942797A/en not_active Abandoned
- 1997-08-07 DE DE59711379T patent/DE59711379D1/de not_active Expired - Lifetime
- 1997-08-11 MY MYPI97003670A patent/MY117606A/en unknown
- 1997-08-15 TW TW086111729A patent/TW518226B/zh not_active IP Right Cessation
- 1997-08-19 AR ARP970103769A patent/AR008304A1/es active IP Right Grant
-
2000
- 2000-03-08 HK HK00101449A patent/HK1022435A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2263584A1 (en) | 1998-02-26 |
| KR100493577B1 (ko) | 2005-06-10 |
| KR20000068070A (ko) | 2000-11-25 |
| BR9711338B1 (pt) | 2009-01-13 |
| TW518226B (en) | 2003-01-21 |
| AU3942797A (en) | 1998-03-06 |
| CA2263584C (en) | 2008-12-23 |
| JP4338222B2 (ja) | 2009-10-07 |
| ES2213829T3 (es) | 2004-09-01 |
| CN1228023A (zh) | 1999-09-08 |
| MY117606A (en) | 2004-07-31 |
| HK1022435A1 (en) | 2000-08-11 |
| US5808076A (en) | 1998-09-15 |
| BR9711338A (pt) | 1999-08-17 |
| EP0920317B1 (de) | 2004-03-03 |
| EP0920317A1 (de) | 1999-06-09 |
| DK0920317T3 (da) | 2004-07-05 |
| DE59711379D1 (de) | 2004-04-08 |
| JP2000516239A (ja) | 2000-12-05 |
| DE19633480A1 (de) | 1998-02-26 |
| ATE260657T1 (de) | 2004-03-15 |
| CN1113651C (zh) | 2003-07-09 |
| WO1998007428A1 (de) | 1998-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR008304A1 (es) | Procedimiento para la obtención de formulaciones aplicables de manera oral de ácidos quinolon-o naftiridoncarboxílicos y granulado preparado por mezclado. | |
| JPS55153712A (en) | Insulin pharmaceutical preparation and its production | |
| ES2010648T3 (es) | Formulaciones farmaceuticas de sustancias labiles frente a los acidos para uso oral. | |
| AR037490A1 (es) | Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos | |
| ES500186A0 (es) | Un metodo, para la preparacion de una formulacion farmaceutica de un agente bioactivo polar. | |
| CO5190688A1 (es) | Formas farmaceuticas de administracion oral al menos parcialmente retardadas cuya sustancia activa tramadol se encuentra al menos parcialmente en forma de compuesto formado in situ con una hidrosolubilidad 100 mg/ml, y procedimientos para su preparac | |
| AR011069A1 (es) | Compuestos amidino, proceso para su preparacion, compuestos intermediarios, formulaciones farmaceuticas que los comprenden, y su uso en la fabricacion de un medicamento como inhibidor de la oxido nitrico sintasa inducible. | |
| ES2054860T3 (es) | Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos. | |
| KR910000138A (ko) | 약제학적 조성물 | |
| AR026064A1 (es) | Compuestos de oxabispidina, formulacion farmaceutica, uso de estos compuestos para la manufactura de medicamentos, proceso para la preparacion de estos compuestos, e intermediarios. | |
| ATE88886T1 (de) | Brausendes nagelmittel. | |
| AR029312A1 (es) | Formas cristalinas de eto2c-ch2-(r)cgl-aze-pab-oh, procesos para su produccion, formulacion farmaceutica, y uso de estos compuestos para la elaboracion de un medicamento. | |
| AR037560A1 (es) | Formulacion de altas dosis de ibandronato | |
| AR024476A1 (es) | Uso de derivados de acido benzacepin-n-acetico, para la elaboracion de preparados farmaceuticos para la profilaxis y/o tratamiento de lesiones cardiacasprocedimiento para su preparacion y productos que los contienen. | |
| SE388851B (sv) | L-asparylaminomalonsyraalkylfenkyldiestrar och fysiologiskt godtagbara salter derav till anvendning som sotningsmedel | |
| AR006345A1 (es) | Una composicion farmaceutica para administracion oral que comprende un inhibidor de proteasa del vih y un derivado de tocoferol soluble en agua, y un metodo para preparar dicha composicion. | |
| DK429480A (da) | Phosphonohydroxyeddikesyre fremgangsmaader til fremstilling deraf samt anvendelse deraf som laegemiddel | |
| ES2184150T3 (es) | Uso de derivados de los acidos 7-(1-aminometil-2-oxa-7-aza-biciclo(3.3.0)oct-7il)-quinoloncarboxilico y -naftiridoncarboxilico para el tratamiento de infecciones causadas por helicobacter pylori y de las afecciones gastroduodenales asociadas con ellas. | |
| DE60100364D1 (de) | Wasserlösliche pharmazeutische Darreichungsform, ausgenommen Brause-Formen, welche nicht-steroidale antientzündliche Wirkstoffe enthält | |
| JPS5661311A (en) | Thial amide or prolonged pharmaceutical preparation comprising its salt | |
| ES2200323T3 (es) | Preparacion farmaceutica que contiene nimesulida para administracion por via oral. | |
| AR021491A1 (es) | Un compuesto de 6-azauracilo que inhibe a il-5, una composicion que lo comprende, un proceso para preparar dicha composicion, y el uso de dicho compuestopara la manufactura de un medicamento y de un agente de diagnostico | |
| DK114286A (da) | Pyridylmethylnaphthylderivater eller fysiologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler | |
| DK401683A (da) | Substituerede benzensulfonsyreestere, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler | |
| JPS5646838A (en) | 2- 2-fluoro-4-biphenylyl propionic acid-cyclodextrin clathrate compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |